Health and Healthcare
Health and Healthcare Articles
Spectrum Pharmaceuticals announced good news for lung cancer patients in its midstage trial on Tuesday.
Published:
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
Published:
Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.
Published:
Pfizer and BioNTech made another big step in their fight against COVID-19 by initiating their late-stage study for their lead mRNA vaccine candidate.
Published:
MediciNova saw the coronavirus bump on Monday after it said it had entered a worldwide exclusive agreement with BioComo for the rights to develop a SARS-CoV-2 vaccine.
Published:
If scientists say anything about arresting the spread of COVID-19, it is to maintain social distance and to wear masks. New research shows that many companies have no plans to ask employees to do so.
Published:
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Most large cities in Spain recently emerged from a months-long lockdown as the rise in the numbers of confirmed cases and COVID-19 deaths dropped sharply. But now, new cases have started to surge...
Published:
The focus of medical discussions in America has largely turned to the causes, symptoms, deaths, and cures for COVID-19. Lost to a signficant extent in the discussion about health is what remains the...
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
A growing number of scientists believe that the increase in daily deaths due to COVID-19 in America is not over.
Published:
Arbutus Biopharma stock has seen an incredible rise over the past few days after the firm won a patent dispute that could have implications for coronavirus vaccine frontrunner Moderna.
Published:
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
Published:
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.
Published:
The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts. Here are seven that...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.